(4-AMINOBICYCLO[2.2.2]OCTAN-1-YL)METHANOL, 95.0%, 1g

Tesevatinib, 99.21%, 2mg

3,5-Dimethylpicolinic acid, 95.0%, 5g

Ethyl 5-bromo-2-methylthiazole-4-carboxylate, 97%, 1g

3,5-Difluorobenzamidine hydrochloride, 95.0%, 5g

GC capillary column ROTI®Cap-1, 10 m, 0.25 mm, 0.10 µm, 1 Piece(s)

3-Bromo-4-ethoxybenzaldehyde, 95.0%, 100g

2-Ethoxy-6-fluorobenzoic acid, 98%, 1g

2-bromo-2-methylpropan-1-ol, 97%, 250mg

Ethyl 3-hydroxy-3-phenylpropanoate, 95.0%, 1g

4-Bromo-3-methoxyaniline, 97.0%, 25g

4'-Methoxyphenyl acetylene, 98.0%, 500g

Ethyl 4-cyanobenzoate, 97.0%, 1g